Invention Grant
- Patent Title: Inhibition of tumour growth
- Patent Title (中): 抑制肿瘤生长
-
Application No.: US11726172Application Date: 2007-03-21
-
Publication No.: US08283315B2Publication Date: 2012-10-09
- Inventor: Liv Tone Eliassen , Gerd Berge , Baldur Sveinbjørnsson , John Sigurd Svendsen , Øystein Rekdal
- Applicant: Liv Tone Eliassen , Gerd Berge , Baldur Sveinbjørnsson , John Sigurd Svendsen , Øystein Rekdal
- Applicant Address: NO Tromso
- Assignee: Lytix Biopharma AS
- Current Assignee: Lytix Biopharma AS
- Current Assignee Address: NO Tromso
- Agency: Fox Rothschild LLP
- Priority: GB9818938.4 19980828; GB0605685.7 20060321
- Main IPC: A61K39/00
- IPC: A61K39/00

Abstract:
The present invention provides a cytotoxic 7 to 25 mer peptide with three or more cationic residues which has one or more non-genetic bulky and lipophilic amino acids, as well as esters, amides, salts and cyclic derivatives thereof as well as methods of preparing the peptides, pharmaceutical compositions containing them and their use as medicaments, particularly as antibacterions or antitumoral agents. In a preferred aspect, the invention provides the use of said peptides in a method of inducing adaptive immunity against tumor growth or establishment in a subject, as well as the use of other lytic agents in a method of inducing adaptive immunity in a subject.
Public/Granted literature
- US20080019993A1 Inhibition of tumour growth Public/Granted day:2008-01-24
Information query